Steven Schutzer from Rutgers New Jersey Medical School is leading a team assessing new vaccine strategies for Lyme disease, including a hybrid approach that can deliver a one-two punch to the microbe that causes the disease and its tick carrier. Learn more.
Recent Posts
- Yibin Kang’s team identifies new path to potential cancer treatments.
- Why a Life-Threatening Sedative Is Being Prescribed More Often for Seniors.
- NJACTS Community Engagement Core Available Services
- Join NJ ACTS for a Seminar on Clinical Research Record Retention on 3/2 at 12
- CTSA Translational Impact Summit on March 2&3 (Virtual) – Register Now!
Categories
- Community (2,443)
- Covid (997)
- CTO Events (6)
- News (3,096)
- Pilots (21)